Hanx Biopharmaceuticals (3378) Announces Proposal for H Share Repurchase Mandate

Bulletin Express01-27

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) released an announcement regarding an upcoming extraordinary general meeting (EGM) scheduled for Thursday, February 12, 2026, at 10:00 a.m. The meeting will be held at the company’s conference room in Wuhan, Hubei Province.

According to the announcement, shareholders will consider granting the board authority to repurchase up to 10% of the total issued H shares (excluding any treasury shares). The proposed mandate, if approved, would permit share repurchases on the Hong Kong Stock Exchange within a defined period. The announcement also explains the procedures for returning proxy forms and clarifies that the closure of the share register is slated for February 9 to February 12, 2026. Shareholders of record on February 12, 2026, will be eligible to attend and vote on the resolution at the EGM.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147175269?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147175269","market":"hk","top_or_hot":-1,"title":"Hanx Biopharmaceuticals (3378) Announces Proposal for H Share Repurchase Mandate","media":"Bulletin Express","content":"<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) released an announcement regarding an upcoming extraordinary general meeting (EGM) scheduled for Thursday, February 12, 2026, at 10:00 a.m. The meeting will be held at the company’s conference room in Wuhan, Hubei Province.</p>\n<p>According to the announcement, shareholders will consider granting the board authority to repurchase up to 10% of the total issued H shares (excluding any treasury shares). The proposed mandate, if approved, would permit share repurchases on the Hong Kong Stock Exchange within a defined period. The announcement also explains the procedures for returning proxy forms and clarifies that the closure of the share register is slated for February 9 to February 12, 2026. Shareholders of record on February 12, 2026, will be eligible to attend and vote on the resolution at the EGM.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hanx Biopharmaceuticals (3378) Announces Proposal for H Share Repurchase Mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHanx Biopharmaceuticals (3378) Announces Proposal for H Share Repurchase Mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-27 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) released an announcement regarding an upcoming extraordinary general meeting (EGM) scheduled for Thursday, February 12, 2026, at 10:00 a.m. The meeting will be held at the company’s conference room in Wuhan, Hubei Province.</p>\n<p>According to the announcement, shareholders will consider granting the board authority to repurchase up to 10% of the total issued H shares (excluding any treasury shares). The proposed mandate, if approved, would permit share repurchases on the Hong Kong Stock Exchange within a defined period. The announcement also explains the procedures for returning proxy forms and clarifies that the closure of the share register is slated for February 9 to February 12, 2026. Shareholders of record on February 12, 2026, will be eligible to attend and vote on the resolution at the EGM.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03378","symbol_name":"翰思艾泰-B","start_time":0,"source_url":"","article_id":"1147175269","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147175269","pubTimestamp":1769521493,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) released an announcement regarding an upcoming extraordinary general meeting (EGM) scheduled for Thursday, February 12, 2026, at 10:00...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03378":"翰思艾泰-B"},"translate_title":"汉克斯生物制药(3378)公布H股购回授权建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1},"content_text":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) released an announcement regarding an upcoming extraordinary general meeting (EGM) scheduled for Thursday, February 12, 2026, at 10:00 a.m. The meeting will be held at the company’s conference room in Wuhan, Hubei Province.\nAccording to the announcement, shareholders will consider granting the board authority to repurchase up to 10% of the total issued H shares (excluding any treasury shares). The proposed mandate, if approved, would permit share repurchases on the Hong Kong Stock Exchange within a defined period. The announcement also explains the procedures for returning proxy forms and clarifies that the closure of the share register is slated for February 9 to February 12, 2026. Shareholders of record on February 12, 2026, will be eligible to attend and vote on the resolution at the EGM.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147175269","isCrawlerRequest":true}